Curis Inc.

Curis Inc.
Stock Exchange NASDAQ Stock Market
EPS
$0.96
Market Cap
$59.34 M
Shares Outstanding
33.15 M
Public Float
27.18 M

Profile

Address
4 Maguire Road
Lexington Massachusetts 02421
United States
Employees -
Website http://www.curis.com
Updated 07/08/2019
Curis, Inc. is a biotechnology company, which is focused on the development and commercialization of drug candidates for the treatment of human cancers. Its pipeline includes CUDC-907, CA-170, and CA-327. The CUDC-907 pipeline is an orally available small molecule inhibitor of HDAC and PI3K enzymes.

Financials

View All

Ali Fattaey
President, Chief Executive Officer & Director
Lori Anne Kunkel
Director